Research Article Details
| Article ID: | A46791 |
| PMID: | 15508909 |
| Source: | Nutr Rev |
| Title: | Central obesity and elevated liver enzymes. |
| Abstract: | Nonalcoholic fatty liver disease is commonly associated with obesity, a growing epidemic worldwide. A new large, population-based investigation has shown a statistically significant association between central adiposity and elevated liver enzymes. This finding adds to the growing research specifically linking central adiposity, and more specifically, visceral adiposity, with adverse health effects. |
| DOI: | 10.1111/j.1753-4887.2004.tb00010.x |
| Strategy ID | Therapy Strategy | Synonyms | Therapy Targets | Therapy Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class | |
|---|---|---|---|---|---|
| I14 | 9970 | Obesity | An overnutrition that is characterized by excess body fat, traditionally defined as an elevated ratio of weight to height (specifically 30 kilograms per meter squared), has_material_basis_in a multifactorial etiology related to excess nutrition intake, decreased caloric utilization, and genetic susceptibility, and possibly medications and certain disorders of metabolism, endocrine function, and mental illness. https://en.wikipedia.org/wiki/Obesity | disease of metabolism/acquired metabolic disease/ nutrition disease/overnutrition | Details |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|